Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
4.190
-0.440 (-9.50%)
Jun 20, 2025, 1:06 PM - Market open
Y-mAbs Therapeutics Market Cap
Y-mAbs Therapeutics has a market cap or net worth of $189.79 million as of June 20, 2025. Its market cap has decreased by -64.17% in one year.
Market Cap
189.79M
Enterprise Value
130.54M
1-Year Change
-64.17%
Ranking
Category
Stock Price
$4.19
Market Cap Chart
Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $189.79M, a decrease of -76.18%. That is a compound annual growth rate of -19.16%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.60B |
| Johnson & Johnson | 359.49B |
| Novo Nordisk | 333.14B |
| AbbVie | 325.71B |
| UnitedHealth Group | 276.22B |
| Abbott Laboratories | 230.84B |
| Novartis AG | 227.73B |
| AstraZeneca | 219.65B |